Robot-Assisted Treatment of Symptomatic Lymphocele Postradical Prostatectomy and Lymphadenectomy in the Era or Robotic Surgery: Narrative Review
Technology in Cancer Research & Treatment · 2023
DOI: 10.1177/15330338221145248 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Technology in Cancer Research & Treatment, 2023. Verfasst von Luca Di Gianfrancesco und 5 weiteren Autor:innen. Beteiligte Einrichtung: Veneto Institute of Oncology (IOV) IRCCS, Padua, Italy at the headquarters of Castelfranco Veneto, Treviso, Italy. Hauptthemen laut MEDLINE: Robotic Surgical Procedures, Robotics, Prostatic Neoplasms, Lymphocele. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Pelvic lymphnode dissection (PLND) is an integral part of surgical treatment for localized intermediate and high-risk prostate cancer. The most common complication of PLND is lymphocele formation. In the majority of cases the development of lymphoceles is clinically asymptomatic but in case of symptomatic/infected lymphocele an active treatment is required. The aim of this article is to analyse the current evidence on the treatment of symptomatic/infected lymphocele trough robotic approach. Materials and Methods: The search was applied to PubMed, EMBASE, and Cochrane databases with following terms: “lymphocele”, “symptomatic”, “infected”, “robot-assisted AND radical prostatectomy”, “robot-assisted”, “treatment”.
Results
The search identified three series focusing on the treatment by robot-assisted approach of symptomatic and/or infected lymphocele. The main and most frequent reason for performing the robotic treatment was an infected lymphocele, the median time from robot-assisted radical prostatectomy and PLND to robotic treatment of lymphocele was 118 days (range 30-240). Robot-assisted treatment was successful in all reports.
Conclusions
The drainage of lymphocele with the robot-assisted approach appeared safe, feasible, and with satisfactory outcomes for the definitive treatment of symptomatic/infected lymphocele.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Veneto Institute of Oncology (IOV) IRCCS, Padua, Italy at the headquarters of Castelfranco Veneto, Treviso, Italy.
ORCID-Profile: Luca Di Gianfrancesco
Zitieren
APA
Di Gianfrancesco, L., Alessandro, C., Paolo, C., Davide, M., Eugenio, M., & Angelo, P. (2023). Robot-Assisted Treatment of Symptomatic Lymphocele Postradical Prostatectomy and Lymphadenectomy in the Era or Robotic Surgery: Narrative Review. Technology in Cancer Research & Treatment. https://doi.org/10.1177/15330338221145248
Vancouver
Di Gianfrancesco L, Alessandro C, Paolo C, Davide M, Eugenio M, Angelo P. Robot-Assisted Treatment of Symptomatic Lymphocele Postradical Prostatectomy and Lymphadenectomy in the Era or Robotic Surgery: Narrative Review. Technology in Cancer Research & Treatment. 2023. doi:10.1177/15330338221145248
BibTeX
@article{DiGianfrancesco2023,
author = {Di Gianfrancesco, Luca and Alessandro, Crestani and Paolo, Corsi and Davide, De Marchi and Eugenio, Miglioranza and Angelo, Porreca},
title = {Robot-Assisted Treatment of Symptomatic Lymphocele Postradical Prostatectomy and Lymphadenectomy in the Era or Robotic Surgery: Narrative Review},
journal = {Technology in Cancer Research & Treatment},
year = {2023},
doi = {10.1177/15330338221145248}
}
EUVIMED